Gains in childhood cancer survival slow

02/19/2013 | Bloomberg Businessweek

Although the five-year survival rate of children with cancer increased from 30% in the 1960s to 80% in the 2000s, improvement has leveled off, physicians wrote in Lancet Oncology. The report's authors say the approach to research and regulation must be modernized to address the issue. Just 15 childhood cancer drugs have been allowed for use in children since 1998.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ